Biosphere tenant Iksuda Therapeutics enters licensing agreement with LegoChem Biosciences

By |2020-08-06T09:25:33+00:00May 27th, 2020|News|

LegoChem Biosciences and Iksuda enter Licensing Agreement for Antibody Drug Conjugate program Iksuda gains… Continue Reading Biosphere tenant Iksuda Therapeutics enters licensing agreement with LegoChem Biosciences

Comments Off on Biosphere tenant Iksuda Therapeutics enters licensing agreement with LegoChem Biosciences
Go to Top